{"transactions":[{"id":1965461,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":115836,"kind":"person","name":"Larkin Finbar","position":1,"cik":"0001793243","reported_name":"Larkin Finbar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-03-08T02:33:21.000Z","date":"2023-03-06","kind":"exercise","acquired":false,"shares":1706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vested over four years measured from the grant date, May 3, 2013, with 1/4th vesting on April 9, 2014 and the remainder vesting in 36 equal monthly installments thereafter. The option is fully vested and exercisable as of the date of this Form."}],"balance_after":0,"derivative":{"exercise_price":58.72,"expiration_date":"2023-05-02","underlying":"Ordinary Shares","underlying_shares":1706},"source":{"system":"sec-edgar","filing":"0001765581-23-000032","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000032/edgardoc.xml","form_type":"4"}},{"id":1965460,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":115836,"kind":"person","name":"Larkin Finbar","position":1,"cik":"0001793243","reported_name":"Larkin Finbar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Ordinary Shares","published_at":"2023-03-08T02:33:21.000Z","date":"2023-03-07","kind":"sale","acquired":false,"shares":2075,"price":140.7619,"value":292080.9425,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $140.7578 to $140.7656 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":21779,"source":{"system":"sec-edgar","filing":"0001765581-23-000032","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000032/edgardoc.xml","form_type":"4"}},{"id":1965459,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":115836,"kind":"person","name":"Larkin Finbar","position":1,"cik":"0001793243","reported_name":"Larkin Finbar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Ordinary Shares","published_at":"2023-03-08T02:33:21.000Z","date":"2023-03-06","kind":"sale","acquired":false,"shares":1706,"price":143.919,"value":245525.814,"ownership":{"direct":true},"balance_after":23854,"source":{"system":"sec-edgar","filing":"0001765581-23-000032","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000032/edgardoc.xml","form_type":"4"}},{"id":1965458,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":115836,"kind":"person","name":"Larkin Finbar","position":1,"cik":"0001793243","reported_name":"Larkin Finbar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Ordinary Shares","published_at":"2023-03-08T02:33:21.000Z","date":"2023-03-06","kind":"exercise","acquired":true,"shares":1706,"price":58.72,"value":100176.32,"ownership":{"direct":true},"balance_after":25560,"source":{"system":"sec-edgar","filing":"0001765581-23-000032","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000032/edgardoc.xml","form_type":"4"}},{"id":1965457,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":115836,"kind":"person","name":"Larkin Finbar","position":1,"cik":"0001793243","reported_name":"Larkin Finbar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Ordinary Shares","published_at":"2023-03-08T02:33:21.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":4373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2023, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 72 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2022."}],"balance_after":23854,"source":{"system":"sec-edgar","filing":"0001765581-23-000032","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000032/edgardoc.xml","form_type":"4"}},{"id":2114346,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":115836,"kind":"person","name":"Larkin Finbar","position":1,"cik":"0001793243","reported_name":"Larkin Finbar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Ordinary Shares","published_at":"2022-11-16T22:58:58.000Z","date":"2022-11-14","kind":"sale","acquired":false,"shares":197,"price":149.33,"value":29418.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":19409,"source":{"system":"sec-edgar","filing":"0001765581-22-000122","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000122/edgardoc.xml","form_type":"4"}},{"id":2162125,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":115836,"kind":"person","name":"Larkin Finbar","position":1,"cik":"0001793243","reported_name":"Larkin Finbar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Ordinary Shares","published_at":"2022-09-09T22:13:46.000Z","date":"2022-09-07","kind":"sale","acquired":false,"shares":63,"price":150,"value":9450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 86 ordinary shares, share quantity adjusted for rounding, purchased on March 25, 2022 by Irish Pensions Trust Limited, as trustee for and on behalf of the Reporting Person, as sole beneficiary, pursuant to an Irish Revenue approved profit share scheme in transactions exempt under Rule 16b-3(c).\n\nAlso includes 121 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2022."}],"balance_after":19606,"source":{"system":"sec-edgar","filing":"0001765581-22-000114","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000114/edgardoc.xml","form_type":"4"}},{"id":2274613,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":115836,"kind":"person","name":"Larkin Finbar","position":1,"cik":"0001793243","reported_name":"Larkin Finbar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Ordinary Shares","published_at":"2022-05-11T21:35:14.000Z","date":"2022-05-09","kind":"sale","acquired":false,"shares":1747,"price":148.9369,"value":260192.7643,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.92 to $149.91 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":19462,"source":{"system":"sec-edgar","filing":"0001765581-22-000049","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000049/edgardoc.xml","form_type":"4"}},{"id":2341464,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":115836,"kind":"person","name":"Larkin Finbar","position":1,"cik":"0001793243","reported_name":"Larkin Finbar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Ordinary Shares","published_at":"2022-03-09T22:56:17.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":4621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2022, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 120 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2021."}],"balance_after":21209,"source":{"system":"sec-edgar","filing":"0001765581-22-000021","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000021/edgardoc.xml","form_type":"4"}},{"id":2510284,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":115836,"kind":"person","name":"Larkin Finbar","position":1,"cik":"0001793243","reported_name":"Larkin Finbar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Ordinary Shares","published_at":"2021-11-16T21:13:53.000Z","date":"2021-11-12","kind":"sale","acquired":false,"shares":197,"price":135.79,"value":26750.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer for cashless exercise of nonstatutory stock options solely to cover exercise price and required withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 86 ordinary shares, share quantity adjusted for rounding, purchased on March 15, 2021 by Irish Pensions Trust Limited, as trustee for and on behalf of the Reporting Person, as sole beneficiary, pursuant to an Irish Revenue approved profit share scheme in transactions exempt under Rule 16b-3(c).\n\nAlso includes 123 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 28, 2021."}],"balance_after":16468,"source":{"system":"sec-edgar","filing":"0001765581-21-000127","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000127/edgardoc.xml","form_type":"4"}},{"id":2573062,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":115836,"kind":"person","name":"Larkin Finbar","position":1,"cik":"0001793243","reported_name":"Larkin Finbar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Ordinary Shares","published_at":"2021-09-10T20:01:30.000Z","date":"2021-09-08","kind":"sale","acquired":false,"shares":63,"price":134.51,"value":8474.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer for cashless exercise of nonstatutory stock options solely to cover exercise price and required withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 86 ordinary shares, share quantity adjusted for rounding, purchased on March 15, 2021 by Irish Pensions Trust Limited, as trustee for and on behalf of the Reporting Person, as sole beneficiary, pursuant to an Irish Revenue approved profit share scheme in transactions exempt under Rule 16b-3(c).\n\nAlso includes 123 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 28, 2021."}],"balance_after":16579,"source":{"system":"sec-edgar","filing":"0001765581-21-000118","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000118/edgardoc.xml","form_type":"4"}},{"id":2796654,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":115836,"kind":"person","name":"Larkin Finbar","position":1,"cik":"0001793243","reported_name":"Larkin Finbar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Ordinary Shares","published_at":"2021-03-10T21:27:49.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":1509,"price":161.603,"value":243858.927,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $161.5994 to $161.6046. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":16519,"source":{"system":"sec-edgar","filing":"0001765581-21-000046","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000046/edgardoc.xml","form_type":"4"}},{"id":2825853,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":115836,"kind":"person","name":"Larkin Finbar","position":1,"cik":"0001793243","reported_name":"Larkin Finbar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Ordinary Shares","published_at":"2021-03-01T22:57:51.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":3950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2021, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 114 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2020."}],"balance_after":18028,"source":{"system":"sec-edgar","filing":"0001765581-21-000022","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000022/edgardoc.xml","form_type":"4"}},{"id":2986248,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":115836,"kind":"person","name":"Larkin Finbar","position":1,"cik":"0001793243","reported_name":"Larkin Finbar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Ordinary Shares","published_at":"2020-11-10T23:16:20.000Z","date":"2020-11-06","kind":"sale","acquired":false,"shares":197,"price":151.93,"value":29930.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":13964,"source":{"system":"sec-edgar","filing":"0001765581-20-000113","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000113/edgardoc.xml","form_type":"4"}},{"id":3034230,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":115836,"kind":"person","name":"Larkin Finbar","position":1,"cik":"0001793243","reported_name":"Larkin Finbar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Ordinary Shares","published_at":"2020-09-10T22:48:34.000Z","date":"2020-09-09","kind":"sale","acquired":false,"shares":63,"price":138.53,"value":8727.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 106 and 132 ordinary shares purchased on March 15, 2019 and March 13, 2020 respectively by Irish Pensions Trust Limited, as trustee for and on behalf of the Reporting Person, as sole beneficiary, pursuant to an Irish Revenue approved profit share scheme in transactions exempt under Rule 16b-3(c).\n\nAlso includes 103 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 29, 2020."}],"balance_after":14161,"source":{"system":"sec-edgar","filing":"0001765581-20-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000097/edgardoc.xml","form_type":"4"}},{"id":3217487,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":115836,"kind":"person","name":"Larkin Finbar","position":1,"cik":"0001793243","reported_name":"Larkin Finbar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Ordinary Shares","published_at":"2020-03-10T22:06:31.000Z","date":"2020-03-09","kind":"sale","acquired":false,"shares":615,"price":111.489,"value":68565.735,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $111.4701 to $111.5101. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":13883,"source":{"system":"sec-edgar","filing":"0001765581-20-000043","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000043/edgardoc.xml","form_type":"4"}},{"id":3217486,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":115836,"kind":"person","name":"Larkin Finbar","position":1,"cik":"0001793243","reported_name":"Larkin Finbar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Ordinary Shares","published_at":"2020-03-10T22:06:31.000Z","date":"2020-03-06","kind":"sale","acquired":false,"shares":292,"price":119.1543,"value":34793.0556,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":14498,"source":{"system":"sec-edgar","filing":"0001765581-20-000043","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000043/edgardoc.xml","form_type":"4"}},{"id":3224327,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":115836,"kind":"person","name":"Larkin Finbar","position":1,"cik":"0001793243","reported_name":"Larkin Finbar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Ordinary Shares","published_at":"2020-03-06T00:44:20.000Z","date":"2020-03-03","kind":"sale","acquired":false,"shares":279,"price":119.7499,"value":33410.2221,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":14790,"source":{"system":"sec-edgar","filing":"0001765581-20-000030","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000030/edgardoc.xml","form_type":"4"}},{"id":3237753,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":115836,"kind":"person","name":"Larkin Finbar","position":1,"cik":"0001793243","reported_name":"Larkin Finbar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-03-02T23:35:17.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 27, 2020, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":12500,"derivative":{"exercise_price":113.1,"expiration_date":"2030-02-26","underlying":"Ordinary Shares","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001765581-20-000022","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000022/edgardoc.xml","form_type":"4"}},{"id":3237752,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":115836,"kind":"person","name":"Larkin Finbar","position":1,"cik":"0001793243","reported_name":"Larkin Finbar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Ordinary Shares","published_at":"2020-03-02T23:35:17.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2020, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 81 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 29, 2019."}],"balance_after":15069,"source":{"system":"sec-edgar","filing":"0001765581-20-000022","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000022/edgardoc.xml","form_type":"4"}},{"id":3376203,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":115836,"kind":"person","name":"Larkin Finbar","position":1,"cik":"0001793243","reported_name":"Larkin Finbar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Ordinary Shares","published_at":"2019-11-08T23:24:08.000Z","date":"2019-11-07","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of November 5, 2019, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":9988,"source":{"system":"sec-edgar","filing":"0001765581-19-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558119000094/edgardoc.xml","form_type":"4"}}]}